AXIM Biotechnologies (AXIM) 10-Q2017 Q1 Quarterly report

Filed: 22 May 17, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. freshman Avg

New words: absent, absolute, adequate, adverse, afer, agency, aggregate, Air, Allied, American, antifungal, Article, aspect, attestation, aware, banking, Barney, began, Blake, Bob, Bond, broker, Burnham, California, career, chairman, charitable, Chicago, Christian, church, circumvented, circumvention, College, combination, conceived, concentrated, contemplating, COSO, Cunningham, Dealer, dealing, deficiency, Department, detail, detect, detected, detection, deteriorate, Diego, dining, disposed, disposition, Drexel, Earth, error, Esq, estate, experience, external, fact, fairly, family, fast, faulty, firm, Forevergreen, founding, fraud, global, goodwill, governmental, group, growing, HD, hiring, homeopathic, Hospitality, Huemoeller, human, ICH, inadequate, individual, John, joining, Joshua, Justice, Kannaway, lack, Lake, Lekharm, leveraged, local, matter, million, misstatement, mistake, modification, MonaVie, monthly, mortgage, multinational, nationwide, Naturewell, omitted, opening, overriding, oversight, owed, owner, Pacific, partially, partner, pastor, PDP, personnel, PhD, Phillip, Philosophy, Placer, Plaza, prevent, prevented, prevention, proceeding, Professor, Propell, properly, provinceof, Prudential, publicly, real, rectify, reliability, Religion, rent, renting, repaid, resource, Revised, Rockefeller, Salt, San, Schroeder, Scott, screen, segregate, segregation, senior, shareholder, similar, single, small, Smith, specific, Sponsoring, succeed, Suite, supply, Syracuse, Theology, Timothy, Treadway, treated, Tree, Trustee, unauthorized, UT, Utah, venture, Vermillion, vice, Wall, Webber, yearend

Removed: accompanying, consulting, East, initial, province

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

AXIM similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Report of AXIM Biotechnologies, Inc., a Nevada Corporation, (the “Company”) on Form 10-Q for the period ended March 31, 2017, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned certify the following pursuant to Section 18, U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002:


1.	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


2.	The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.

May 22, 2017

/s/ Robert Malasek

Robert Malasek

Chief Financial Officer

Principal Accounting Officer